Synovus Financial Corp Thermo Genesis Holdings, Inc. Transaction History

Synovus Financial Corp

  • $8.56 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020
SELL
$3.36 - $12.21 $3 - $12
-1 Closed
0 $0
Q1 2020

Apr 24, 2020
BUY
$1.72 - $5.8 $1 - $5
1 New
1 $0

About ThermoGenesis Holdings, Inc.

THMO Quotes by TradingView
  • Ticker THMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,321,400
  • Description
  • ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally cl...
More about THMO
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email